Fibroblast Revenue and Competitors
Claim your profile
Estimated Revenue & Valuation
- Fibroblast's estimated annual revenue is currently $2.6M per year.
- Fibroblast's estimated revenue per employee is $101,500
Employee Data
- Fibroblast has 26 Employees.
Fibroblast Competitors & Alternatives
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $2M | 20 | N/A | N/A | N/A |
#2 | $4.2M | 22 | N/A | N/A | N/A |
#3 | $22.3M | 262 | 43% | $4.7M | N/A |
#4 | $1.9M | 12 | N/A | N/A | N/A |
#5 | $64.1M | 221 | -3% | $46.7M | N/A |
#6 | $70.1M | 541 | -13% | $27.1M | N/A |
#7 | $15.8M | 113 | 16% | N/A | N/A |
#8 | $2.8M | 17 | N/A | N/A | N/A |
#9 | $0.4M | 6 | N/A | N/A | N/A |
#10 | $6.8M | 0 | N/A | $13.5M | N/A |
#11 | $1.4M | 16 | N/A | N/A | N/A |
#12 | $189.6M | 852 | -10% | $195.3M | $1.7B |
What Is Fibroblast?
N/A
Total Funding
26
Number of Employees
$2.6M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Fibroblast News
2022-04-17 - Steroid-induced fibroblast growth factors drive an epithelial ...
The authors found that patients with severe asthma had increased corticosteroid-driven fibroblast growth factor (FGF) expression.
2022-04-17 - High C-terminal fibroblast growth factor-23 in CKD | IJGM
High C-Terminal Fibroblast Growth Factor-23, Intact Parathyroid Hormone, and Interleukin-6 as Determinants of Valvular Calcification in...
2022-04-13 - Sphingolipids control dermal fibroblast heterogeneity
Human dermal fibroblasts are cell constituents of our skin that display cell-to-cell phenotypic heterogeneity as a result of their dynamic cell...
Other Companies in Chicago
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.7M | 26 | -41% | N/A |
#2 | $3.8M | 26 | -10% | N/A |
#3 | $2.6M | 26 | N/A | N/A |
#4 | $2.5M | 26 | N/A | N/A |
#5 | $2.6M | 26 | N/A | N/A |
